{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:04:30Z","timestamp":1791835470842,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.jconrel.2006.07.023","type":"journal-article","created":{"date-parts":[[2006,7,30]],"date-time":"2006-07-30T02:01:00Z","timestamp":1154224860000},"page":"140-149","source":"Crossref","is-referenced-by-count":95,"title":["Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs"],"prefix":"10.1016","volume":"115","author":[{"given":"Jhi-Joung","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.C.","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver Yoa-Pu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hui","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-You","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2006.07.023_bib1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2165\/00003495-199141030-00002","article-title":"Opioid agonist\u2013antagonist drugs in acute and chronic pain states","volume":"41","author":"Hoskin","year":"1991","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2006.07.023_bib2","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/j.1552-4604.1987.tb05581.x","article-title":"The disposition and bioavailability of intravenous and oral nalbuphine in healthy volunteers","volume":"27","author":"Lo","year":"1987","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2006.07.023_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0378-5173(01)00649-4","article-title":"Controlled release of nalbuphine propionate from biodegradable microspheres: in vitro and in vivo studies","volume":"220","author":"Yen","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2006.07.023_bib4","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1213\/01.ANE.0000078589.90903.EF","article-title":"The antinociceptive effect of nalbuphine and its long-acting esters in rats","volume":"97","author":"Chu","year":"2003","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.jconrel.2006.07.023_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0168-3659(02)00323-1","article-title":"A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration","volume":"86","author":"Lundberg","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2006.07.023_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-5173(03)00365-X","article-title":"Improvement of cefpodoxime proxetil oral absorption in rats by an oil-in-water submicron emulsion","volume":"263","author":"Nicolaos","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2006.07.023_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0169-409X(00)00102-2","article-title":"Disposition characteristics of emulsions and incorporated drugs after systemic or local injection","volume":"45","author":"Kawakami","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2006.07.023_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-5173(97)00369-4","article-title":"The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions","volume":"163","author":"Jumma","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2006.07.023_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0378-5173(87)90115-3","article-title":"Prodrugs for improved oral nalbuphine bioavailability: inter-species differences in the disposition of nalbuphine and its acetylsalicylate and anthranilate esters","volume":"38","author":"Aungst","year":"1987","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2006.07.023_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0378-5173(03)00110-8","article-title":"Biodegradable polymeric microspheres for nalbuphine prodrug controlled delivery: in vitro characterization and in vivo pharmacokinetic studies","volume":"257","author":"Liu","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2006.07.023_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0168-3659(00)00363-1","article-title":"Oil components modulate physical characteristics and function of the natural oil emulsions as drug or gene delivery system","volume":"71","author":"Chung","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2006.07.023_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0168-3659(00)00370-9","article-title":"Sustained elevated plasma aprotinin concentration in mice following intraperitoneal injections of w\/o emulsions incorporating aprotinin","volume":"71","author":"Bjerregaard","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2006.07.023_bib13","series-title":"Soybeans: Chemistry, Technology, and Utilization","first-page":"26","author":"Liu","year":"1999"},{"key":"10.1016\/j.jconrel.2006.07.023_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0939-6411(99)00081-8","article-title":"The influence of alkali fatty acids on the properties and the stability of parenteral o\/w emulsions modified with Solutol HS15\u00ae","volume":"49","author":"Buszello","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2006.07.023_bib15","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/jps.10065","article-title":"Amphotericin B in oil\u2013water lecithin-based microemulsions: formulation and toxicity evaluation","volume":"91","author":"Brime","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2006.07.023_bib16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1021\/js970258w","article-title":"Triglyceride-based microemulsion for intravenous administration of sparingly soluble substances","volume":"87","author":"von Corswant","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2006.07.023_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0939-6411(02)00057-7","article-title":"Parenteral emulsions stabilized with a mixture of phospholipids and PEG-660-12-hydroxy-stearate: evaluation of accelerated and long-term stability","volume":"54","author":"Jumaa","year":"2002","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2006.07.023_bib18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/jps.10064","article-title":"The effect of surface charge and partition coefficient on the chemical stability of solutes in o\/w emulsions","volume":"91","author":"Pongcharoenkiat","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2006.07.023_bib19","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1002\/jps.2600831108","article-title":"Polyethylene glycol modified phospholipids stabilize emulsions prepared from triacylglycerol","volume":"83","author":"Wheeler","year":"1994","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2006.07.023_bib20","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1023\/A:1016274801930","article-title":"Long-circulating emulsions (oil-in-water) as carriers for lipophilic drugs","volume":"12","author":"Liu","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2006.07.023_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10717540490280697","article-title":"Lipid nano\/submicron emulsions as vehicles for topical flurbiprofen delivery","volume":"11","author":"Fang","year":"2004","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2006.07.023_bib22","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1021\/js950120i","article-title":"Paclitaxel partitioning into lipid bilayers","volume":"85","author":"Wenk","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2006.07.023_bib23","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.addr.2003.12.004","article-title":"Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs","volume":"56","author":"Lukyanov","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2006.07.023_bib24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0928-0987(01)00138-5","article-title":"Physicochemical characterization of a drug-containing phospholipid-stabilized o\/w emulsion for intravenous administration","volume":"13","author":"Nord\u00e9n","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2006.07.023_bib25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0378-5173(99)00029-0","article-title":"Preparation and evaluation of flurbiprofen-loaded microemulsion for parenteral delivery","volume":"181","author":"Park","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2006.07.023_bib26","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1248\/cpb.42.1297","article-title":"Permeation of diclofenac salts through silicone membrane: a mechanistic study of percutaneous absorption of ionizable drugs","volume":"42","author":"Maitani","year":"1994","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2006.07.023_bib27","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/jps.20238","article-title":"Bioconversion of naltrexone and its 3-O-alkyl-ester prodrugs in a human skin equivalent","volume":"94","author":"Hammell","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2006.07.023_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.colsurfb.2004.05.016","article-title":"Interaction between erythrocytes and free phospholipids as an emulsifying agent in fat emulsions or drug carrier emulsions for intravenous injections","volume":"37","author":"Ishii","year":"2004","journal-title":"Colloids Surf., B Biointerfaces"},{"key":"10.1016\/j.jconrel.2006.07.023_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijpharm.2004.04.009","article-title":"Interaction of electrically neutral and cationic forms of imipramine with liposome and erythrocyte membranes","volume":"279","author":"Ahyayauch","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2006.07.023_bib30","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1476-5381.1988.tb11679.x","article-title":"Differential sensitivity of antinociceptive tests to opioid agonists and partial agonists","volume":"95","author":"Shaw","year":"1988","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2006.07.023_bib31","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1021\/js9600336","article-title":"Synthesis, opioid receptor affinity, and enzymatic hydrolysis of sterically hindered morphine 3-esters","volume":"85","author":"Mignat","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2006.07.023_bib32","first-page":"102","article-title":"An innovative cold tail-flick test: the cold ethanol tail-flick test","volume":"80","author":"Wang","year":"1995","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.jconrel.2006.07.023_bib33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.2042-7158.1988.tb06310.x","article-title":"Prodrug behavior of nicotinoylmorphine esters","volume":"40","author":"Broekkamp","year":"1988","journal-title":"J. Pharm. Pharmacol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365906003622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365906003622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T13:54:02Z","timestamp":1547474042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365906003622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0168365906003622"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2006.07.023","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}